Paul Voziyan

2.9k total citations
60 papers, 2.3k citations indexed

About

Paul Voziyan is a scholar working on Molecular Biology, Clinical Biochemistry and Nephrology. According to data from OpenAlex, Paul Voziyan has authored 60 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 24 papers in Clinical Biochemistry and 12 papers in Nephrology. Recurrent topics in Paul Voziyan's work include Advanced Glycation End Products research (22 papers), Chronic Kidney Disease and Diabetes (10 papers) and Cell Adhesion Molecules Research (9 papers). Paul Voziyan is often cited by papers focused on Advanced Glycation End Products research (22 papers), Chronic Kidney Disease and Diabetes (10 papers) and Cell Adhesion Molecules Research (9 papers). Paul Voziyan collaborates with scholars based in United States, Australia and United Kingdom. Paul Voziyan's co-authors include Billy G. Hudson, Sergei Chetyrkin, George Melnykovych, John Baynes, Thomas Metz, Jeffrey S. Haug, Mark T. Fisher, Jeffry S. Nyman, Eugenia M. Yazlovitskaya and Vadim Pedchenko and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Paul Voziyan

60 papers receiving 2.3k citations

Peers

Countries citing papers authored by Paul Voziyan

Since Specialization

Citations

This map shows the geographic impact of Paul Voziyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Voziyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Voziyan more than expected).

Fields of papers citing papers by Paul Voziyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Voziyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Voziyan. The network helps show where Paul Voziyan may publish in the future.

Co-authorship network of co-authors of Paul Voziyan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Voziyan. A scholar is included among the top collaborators of Paul Voziyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Voziyan. Paul Voziyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A map of glycation and glycoxidation sites in collagen I of human cortical bone: Effects of sex and type 2 diabetes 2024 ·Bone ·Paul Voziyan, Kyle L. Brown, Sasidhar Uppuganti, Micheal Leser, Kristie L. Rose, Jeffry S. Nyman	6
2	Bone Fragility in High Fat Diet-induced Obesity is Partially Independent of Type 2 Diabetes in Mice 2024 ·Calcified Tissue International ·Sasidhar Uppuganti, Amy Creecy, Daniel Fernandes, (unknown), (unknown), Rafay Ahmed, Paul Voziyan, Elizabeth Rendina-Ruedy, Jeffry S. Nyman	1
3	Effect of ribose incubation on physical, chemical, and mechanical properties of human cortical bone 2023 ·Journal of the mechanical behavior of biomedical materials ·Mustafa Ünal, Sasidhar Uppuganti, (unknown), Rafay Ahmed, Jacquelyn S. Pennings, Thomas L. Willett, Paul Voziyan, Jeffry S. Nyman	14
4	Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility 2022 ·Bone ·Thomas L. Willett, Paul Voziyan, Jeffry S. Nyman	36
5	Post-translational modifications in collagen type I of bone in a mouse model of aging 2020 ·Bone ·Amy Creecy, Kyle L. Brown, Kristie L. Rose, Paul Voziyan, Jeffry S. Nyman	23
6	Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney 2018 ·Kidney International ·(unknown), (unknown), Paul Voziyan, Fenghua Zeng, Raymond C. Harris, Billy G. Hudson, Richard M. Caprioli	9
7	Halogens are key cofactors in building of collagen IV scaffolds outside the cell 2018 ·Current Opinion in Nephrology & Hypertension ·Kyle L. Brown, Billy G. Hudson, Paul Voziyan	4
8	Cellular oxidative stress response mediates radiosensitivity in Fus1-deficient mice 2015 ·Cell Death and Disease ·Eugenia M. Yazlovitskaya, Paul Voziyan, Tissa T. Manavalan, Wendell G. Yarbrough, Alla V. Ivanova	16
9	Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes 2013 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Paul Voziyan, Kyle L. Brown, Sergei Chetyrkin, Billy G. Hudson	27
10	A novel radioprotective function for the mitochondrial tumor suppressor protein Fus1 2013 ·Cell Death and Disease ·Eugenia M. Yazlovitskaya, Roman V. Uzhachenko, Paul Voziyan, Wendell G. Yarbrough, Alla V. Ivanova	14
11	Inhibition of Integrin α2β1 Ameliorates Glomerular Injury 2012 ·Journal of the American Society of Nephrology ·Corina M. Borza, Yan Ru Su, Xiwu Chen, Ling Yu, Stacey Mont, Sergei Chetyrkin, Paul Voziyan, Billy G. Hudson, Paul C. Billings, Hyunil Jo, Joel Bennett, William F. DeGrado, Beate Eckes, Roy Zent, Ambra Pozzi	57
12	Regulation of Matrix Synthesis, Remodeling and Accumulation in Glomerulosclerosis 2009 ·Current Pharmaceutical Design ·Ambra Pozzi, Paul Voziyan, Billy G. Hudson, Roy Zent	32
13	Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine 2007 ·Free Radical Biology and Medicine ·Sergei Chetyrkin, (unknown), Amy‐Joan L. Ham, David L. Hachey, Billy G. Hudson, Paul Voziyan	67
14	Pyridoxamine: The Many Virtues of a Maillard Reaction Inhibitor 2005 ·Annals of the New York Academy of Sciences ·Paul Voziyan, Billy G. Hudson	99
15	Designing a High Throughput Refolding Array Using a Combination of the GroEL Chaperonin and Osmolytes 2005 ·Journal of Structural and Functional Genomics ·Paul Voziyan, (unknown), Angela Chao, (unknown), Mark T. Fisher	6
16	Modification of Proteins In Vitro by Physiological Levels of Glucose 2003 ·Journal of Biological Chemistry ·Paul Voziyan, Raja G. Khalifah, Christophe Thibaudeau, Alaattin Yıldız, Jaison Jacob, Anthony S. Serianni, Billy G. Hudson	126
17	Refolding a Glutamine Synthetase Truncation Mutant In Vitro: Identifying Superior Conditions Using a Combination of Chaperonins and Osmolytes 2000 ·Journal of Pharmaceutical Sciences ·Paul Voziyan, (unknown), Mark T. Fisher	27
18	Importance of Phospholipid in the Folding and Conformation of Phosphatidylinositol Transfer Protein: Comparison of Apo and Holo Species 1997 ·Biochemistry ·Paul Voziyan, Jacqueline M. Tremblay, Lynwood R. Yarbrough, George M. Helmkamp	7
19	Differences in sensitivity to farnesol toxicity between neoplastically- and non-neoplastically-derived cells in culture 1994 ·Cancer Letters ·Istvan Adany, Eugenia M. Yazlovitskaya, Jeffrey S. Haug, Paul Voziyan, George Melnykovych	50
20	Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: Effect of phosphatidylcholine 1994 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Jeffrey S. Haug, (unknown), Eugenia M. Yazlovitskaya, Paul Voziyan, George Melnykovych	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact